Skip to main content

Login

Subscribe

Home
About
About JIC Impact Factor: 1.537
Advertise
Author Instructions
Author Submission Portal
Contact
Editorial Board
Subscribe
E-News Signup
Begin Print Subscription
Renew Print Subscription
Issues
Ahead of Print
Archives
Current Issue
Supplements
Online Only
Upcoming Events
Job Board
News
Online Exclusives
Site Sections
Multimedia
Polls
Podcasts
Videos
Webinars
Of Interest
Current Issue Table of Contents
Table of Content Year-to-Date
Editor’s Choice 2018
Editor’s Choice 2017
Events
IAGS
2019
2017
2016
2014
2012
2010
2007
2006
2004
2002
2000

Resource Utilization

February 27, 2012

Related Content

Resource Utilization

Radial Artery Volume Change

High-Dose Adenosine

Walking Impairment and ABI

Interactive Poll

I use nuclear imaging

Frequently: 75% (3 votes)
Rarely: 0% (0 votes)
Never: 25% (1 vote)

Total votes: 4

Current Issue

Volume 31 - Issue 11 - November, 2019

Recent News

AHA: COLCOT Clinical Trial Demonstrates It is Possible to Reduce Risk of CV Events With Low-Cost Drug Already Available

Terumo Acquires Aortica Corporation to Support Continued Growth of Its Vascular Graft Business and Contribute to Personalized Aortic Therapy

REDUCE-IT USA results, in prespecified subgroup analyses, showed cardiovascular risk reductions across all endpoints, including 30% relative risk reduction in all-cause mortality

New Test Can Better Predict Long-Term Death Risk After TAVR

Job Board

Electrophysiology Tech

Manager, Cardiovascular Services

RN, Seasonal - Up to $52/hr

Outpatient Cardiovascular Lab (Cath Lab) Radiologic Technologist (Rad Tech)

Follow us on Twitter

Tweets by @invasivecardiol

Back to Top

Connect

Facebook
Twitter
LinkedIn

About

About Us
Contact Us
Privacy Policy

Visit Our Other Brands

Amputation Prevention Symposium
Cath Lab Digest
EP Lab Digest
IO Learning
International Symposium on Endovascular Therapy
Symposium on Clinical Interventional Oncology
Vascular Disease Management

© 2019 HMP. Journal of Invasive Cardiology is a trademark of HMP. All Rights Reserved.